Therapeutic treatments for blood cell deficiencies
Details for Australian Patent Application No. 2008255138 (hide)
International Classifications
Event Publications
8 January 2009 Application Open to Public Inspection
Published as AU-B-2008255138
8 January 2009 Complete Application Filed
15 January 2009 Amendment Made
The nature of the amendment is as shown in the statement(s) filed 12 Dec 2008
10 June 2010 Alteration of Name
The name of the applicant has been altered to Harbor Biosciences, Inc.
24 February 2011 Application Accepted
Published as AU-B-2008255138
23 June 2011 Standard Patent Sealed
15 September 2011 Alteration of Name
The name of the patentee has been altered to Harbor BioSciences, Inc.
20 October 2011 Corrigenda
Amendments - Amendments Made Under the name Harbor BioSciences, Inc., Application No. 2008255138, delete all reference to.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2008255139-Pharmaceutical composition comprising arsenite for the treatment of malignancy
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
![](/images/main/3dbox_small.png)
- Editable Word format reports
- For IP Professionals
- Multiuser